Back to results
US 2017/0253593 A1Published application
Inhibitors of the fibroblast growth factor receptor
AssigneeBlueprint Medicines Corporation
InventorsNeil Bifulco, JR., Lucian V. DiPietro, Chandrasekhar V. Miduturu
Life of this patent
Estimating the term…
Abstract
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.
Claims17
A compound of Formula Ib, or a pharmaceutically acceptable salt thereof:
- wherein:
- Warhead is a moiety capable of forming a covalent bond with a nucleophile;
- Ring A is a 5-8 membered aryl, 5-12 membered heteroaryl, 3-7 member monocyclic or bicyclic heterocyclyl;
- or 3-12 membered monocyclic or bicyclic cycloalkyl group;
- X is CH;
- R4 is H, C1-6 alkyl, or 3-12 membered cycloalkyl;
- each of R1 and R2 is, independently, halo, cyano, optionally substituted C1-6 alkyl, optionally substituted C1-6 alkoxy, hydroxy, oxo, amino, amido, alkyl urea, optionally substituted 3-7 member heterocyclyl;
- R7 is hydrogen or C1-6 alkyl;
- or R7 together with Ring A forms a 8-12 membered bicyclic heterocyclyl optionally substituted with 1-5 occurrences of R1;
- m is 0-5;
- and
- n is 0-5.
9 more elements
A compound selected from any one of the following:
- Compound
- Number
- Structure
- 4
- 9
- 10
- 12
- 17
- 19
- 20
- 21
- 23
- 25
- 26
- 27
- 35
- 37
- 39
- 40
- 41
- 42
- 43
- 45
- 47
- 49
- 51
- 52
- 53
- 54
26 more elements
Dependencies are inferred from the claim text.